Sign in for the best experience.
As a CHEST member, you’re part of a strong network of clinicians representing every profession and experience level in chest medicine. With us, you can develop personal and professional connections, cultivate your leadership skills, advocate for policies that improve access to health, and advance your career.
JOIN TODAY ABOUT MEMBERSHIP »
Advertisement
The Vaccine Guidance Review Panel—a collaborative effort between CHEST, ATS, AAAAI, and SCCM—announced its endorsement of influenza, RSV, and COVID-19 recommendations for adults and children.
READ MORE »
In a new article, LGBTQ+ at CHEST Interest Group Member-at-Large Hassan Bencheqroun, MD, EMBA, FCCP, highlights how artificial intelligence (AI) could help uncover gaps and biases in LGBTQIA+ patient documentation.
CHEST and the American Thoracic Society (ATS) filed a joint amicus brief in support of a lawsuit challenging the US Food and Drug Administration's (FDA) recent guidance policy that allows unauthorized e-cigarettes and nicotine pouches to be distributed, marketed, and sold in the US market.
The field of pediatric interventional bronchoscopy continues to navigate challenges of smaller pediatric airway sizes, low procedural volumes, and lack of standardized training protocols. In a new CHEST Physician article, members of the Pediatric Chest Medicine Section discuss a patient case and highlight existing options to determine the best procedural option.
A CHEST 2026: Inside Look session recap outlines a case-based discussion on how successful pulmonary hypertension (PH) management often requires integrating hemodynamics, imaging, risk assessment, and patient-specific factors rather than relying on classification schemes alone.
As radiography detects more lung nodules, more clinicians are likely counseling patients regarding consideration of nodule biopsies. In a new CHEST Physician article, members of the Pleural Disease Section discuss acknowledging patient fears about tumor dissemination through tissue sampling or resection while also reassuring them that while tumor dissemination during biopsy is biologically plausible, the clinical risk is exceedingly low.
Join the conversation on social media and connect with members of the CHEST community.
Explore practical, guideline-based education on screening eligibility, high-risk patient identification, and nodule classification.
Test your clinical knowledge and enhance your studies as you prepare for your board exams or practice for the Longitudinal Knowledge Assessment.
Enhance your knowledge of lung cancer diagnosis and management with targeted education resources from CHEST.
When you become an FCCP (Fellow of the American College of Chest Physicians), you play an active role in advancing the field of chest medicine while enjoying the prestige of being associated with a distinctive group of chest medicine professionals.
“I have found being an FCCP to be rewarding on a personal level, as well as a professional level. It has provided me with connections to colleagues nationally and internationally, and it has opened the door to leadership opportunities.”
– Thomas Van der Kloot, MD, FCCP
FIND OUT MORE